JPRN-jRCT2080223943已完成3 期
An Open-label Study to Assess the Effect of JTT-751 as Iron Replacement Therapy in Patients with Iron Deficiency Anemia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 73
研究概览
简要总结
The efficacy and safety of JTT-751 were confirmed in patients with iron deficiency anemia.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Iron deficiency anemia
- •Hemoglobin level of >= 8.0 g/dL and < 11.0 g/d
排除标准
- •* Anemia caused by other than iron deficiency
- •* Serum phosphate < 2.5 mg/dL or >= 4.5 mg/dL
- •* Patients scheduled surgical treatment for gynecological diseases with hypermenorrhea during participation
研究者
相似试验
已完成
3 期
A randomized, double-blinded, parallel-group study in patients with iron deficiency anemiaIron Deficiency AnemiaJPRN-jRCT2080223942JAPAN TABACCO INC.518
已完成
2 期
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsDyslipidemiaNCT00688558Akros Pharma Inc.92
已完成
2 期
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsDyslipidemiaNCT00689442Akros Pharma Inc.105
已完成
2 期
A Phase 2 to Evaluate the Dose-Response Relationship and Safety of JTT-751 in Patients with Iron Deficiency AnemiaIron deficiency anemiaJPRN-jRCT2080223256Japan Tobacco Inc.147
终止
2 期
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque PsoriasisSkin DiseasesPlaque PsoriasisNCT03358290Akros Pharma Inc.13